Prelude Therapeutics Incorporated (PRLD) Tops Q2 EPS by 9c

Go back to Prelude Therapeutics Incorporated (PRLD) Tops Q2 EPS by 9c
(NASDAQ: PRLD) Delayed: 5.73 +0.41 (7.71%)
Previous Close $5.32    52 Week High
Open $5.39    52 Week Low
Day High $5.90    P/E N/A 
Day Low $5.39    EPS
Volume 623,562